Nn8640-4467
Research payments
$2,035,861
Through program year 2025, $2,035,861 in research payments was reported against Nn8640-4467, across 10,742 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $397,789 | 160 |
| 2024 | Research | $471,125 | 1,817 |
| 2023 | Research | $771,458 | 6,252 |
| 2022 | Research | $395,489 | 2,513 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mary Abuzzahab Saint Paul, MN Named on 1,066 payments
- Nelly Mauras Jacksonville, FL Named on 901 payments
- Naznin Dixit Jackson, MS Named on 758 payments
- Iris Gutmark-Little Cincinnati, OH Named on 735 payments
- Bhuvana Sunil Tacoma, WA Named on 466 payments
- Sunil Nayak Greenwood Village, CO Named on 371 payments
- John Fuqua Indianapolis, IN Named on 342 payments
- Andrew Dauber Cincinnati, OH Named on 290 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.